Neue Suche | Kongressdetail
mail
Druckansicht
 
 

12th Tumor Models Boston

Evvnt Promotion / evvnt
-
23.07.2024 - 24.07.2024  The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 8:00 AM - 4:10 PM
 
Kongressthemen
In the wake of the FDA Modernization Act and translational rates of cancer drugs into the clinic at just 20%, it is critical that oncology scientists invest in more translational and predictive models to de-risk the validation of novel targets, predict therapeutic response, and support biomarker discovery.
Kongressorganizer (PCO)
Hanson Wade Group
Anmerkungen
Brochure: https://go.evvnt.com/2397551-3?pid=4832

Speakers: Alexander Adler, Principal Scientist and Research Associate, Regeneron Pharmaceuticals Inc, Alina Ainbinder, Principal Scientist, Takeda Pharmaceuticals Co. Ltd., and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/2397551-2?pid=4832
Herr Alex Domingo
 
Kategorien
Onkologie
Sprache
Englisch
Kongressgebühr
Drug Developer, Researchers and Academic - 2 Day Conference Pass: USD 0.50, Solution Provider - 2 Day Conference Pass: USD 3699.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinÄrzte der WeltEuropean Public Health Association (EUPHA)Hilfswerk AustriaAMREF - African Medical and Research FoundationÖsterreichisches Rotes KreuzÖsterreichische Gesellschaft für Public HealthSwiss Tropical and Public Health Institute